These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3449068)

  • 1. Altered kinetics of etozolin and its active metabolite ozolinone in hepatitis and hepatic cirrhosis with ascites.
    Knauf H; Missmahl M; Schölmerich J; Gerok W; Mutschler E
    Arzneimittelforschung; 1987 Dec; 37(12):1385-8. PubMed ID: 3449068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Independent of etozolin elimination of kidney function. Single dose experiments in patients with renal insufficiency.
    Knauf H; Hasenfuss G; Wais U; Schollmeyer P; Mutschler E
    Arzneimittelforschung; 1980; 30(10):1791-3. PubMed ID: 7192116
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assay of etozolin and its main metabolite, ozolinone, in plasma by high performance liquid chromatography.
    Hengy H; Vollmer KO; Gladigau V; Kölle EU
    Arzneimittelforschung; 1980; 30(10):1788-90. PubMed ID: 7192115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Comparative studies on the diuretic activities of Etozolin and a reference compound in normal volunteers (author's transl)].
    Biamino G
    Arzneimittelforschung; 1977; 27(9a):1814-7. PubMed ID: 578772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Placental transfer of etozolin and ozolinone during the first half of gestation in man.
    Nau H; Steldinger R; Ivan E
    Eur J Clin Pharmacol; 1982; 23(3):253-60. PubMed ID: 7173295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum and ascites levels of macrophage migration inhibitory factor, TNF-alpha and IL-6 in patients with chronic virus hepatitis B and hepatitis cirrhosis.
    Zhang W; Yue B; Wang GQ; Lu SL
    Hepatobiliary Pancreat Dis Int; 2002 Nov; 1(4):577-80. PubMed ID: 14607690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of a new orally active dopamine prodrug, docarpamine, on refractory ascites: a pilot study.
    Funasaki T; Tsutsumi M; Takase S; Tsuchishima M; Ueshima Y; Urashima S; Shimanaka K; Itoh T; Kawahara H
    Am J Gastroenterol; 1999 Sep; 94(9):2475-81. PubMed ID: 10484011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Components of the renin-angiotensin-aldosterone system in plasma and ascites in hepatic cirrhosis.
    Kuiper JJ; Boomsma F; van Buren H; de Man R; Danser AH; van den Meiracker AH
    Eur J Clin Invest; 2008 Dec; 38(12):939-44. PubMed ID: 19021719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of ascites on the pharmacokinetics of amikacin.
    Lanao JM; Dominguez-Gil A; Macias JG; Diez JL; Nieto MJ
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(2):57-61. PubMed ID: 7372376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Metabolism and kinetics of ampicillin elimination in cirrhosis. Therapeutical consequences (author's transl)].
    Chalas J; Labayle D; Macarrio J; Barraud D; Lindenbaum A; Buffet C; Chaput JC
    Sem Hop; 1980 Mar 8-15; 56(9-10):464-9. PubMed ID: 6244668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevation of cytokines in peritoneal fluid and blood in patients with liver cirrhosis.
    Eriksson AS; Gretzer C; Wallerstedt S
    Hepatogastroenterology; 2004; 51(56):505-9. PubMed ID: 15086192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bradykinin in the ascitic fluid of patients with liver cirrhosis.
    Cugno M; Salerno F; Nussberger J; Bottasso B; Lorenzano E; Agostoni A
    Clin Sci (Lond); 2001 Dec; 101(6):651-7. PubMed ID: 11724653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Half-life time or clearance of indocyanine green in patients with liver disease.
    Gilmore IT; Marigold JH; Thompson RP
    Hepatogastroenterology; 1982 Apr; 29(2):55-7. PubMed ID: 7084884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of the diuretic Etozolin (Gö 687) on renal elimination of water and solutes in subjects with normal renal function (author's transl)].
    Scheitza E
    Arzneimittelforschung; 1977; 27(9a):1804-6. PubMed ID: 578770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The significance of urine sodium measurement after furosemide administration in diuretics-unresponsive patients with liver cirrhosis].
    Cho HS; Park GT; Kim YH; Shim SG; Kim JB; Lee OY; Choi HS; Hahm JS; Lee MH
    Taehan Kan Hakhoe Chi; 2003 Dec; 9(4):324-31. PubMed ID: 14695699
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Metabolism of hexobarbital in patients with acute hepatitis and cirrhosis (author's transl)].
    Richter E; Gallenkamp H; Keller B; Brachtel D; Zilly W; Breimer DD
    Z Gastroenterol; 1977 Jun; 15(6):381-8. PubMed ID: 888488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranitidine disposition in severe hepatic cirrhosis.
    Gonzalez-Martin G; Paulos C; Veloso B; Chesta J; Novoa X; Arancibia A
    Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):139-42. PubMed ID: 3557740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dynamics of ascitic fluid in decompensated cirrhosis].
    Milani A; Mazzone M; Rossi L
    Recenti Prog Med; 1999 Feb; 90(2):94-9. PubMed ID: 10208100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatic tissue endothelin-1 levels in chronic liver disease correlate with disease severity and ascites.
    Alam I; Bass NM; Bacchetti P; Gee L; Rockey DC
    Am J Gastroenterol; 2000 Jan; 95(1):199-203. PubMed ID: 10638583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.